These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 20382181)

  • 21. Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients.
    Battaini F; Pascale A; Lucchi L; Pasinetti GM; Govoni S
    Exp Neurol; 1999 Oct; 159(2):559-64. PubMed ID: 10506528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for protein kinase C in associative learning.
    Olds JL; Alkon DL
    New Biol; 1991 Jan; 3(1):27-35. PubMed ID: 2039766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Imipramine, in part through tumor necrosis factor alpha inhibition, prevents cognitive decline and beta-amyloid accumulation in a mouse model of Alzheimer's disease.
    Chavant F; Deguil J; Pain S; Ingrand I; Milin S; Fauconneau B; Pérault-Pochat MC; Lafay-Chebassier C
    J Pharmacol Exp Ther; 2010 Feb; 332(2):505-14. PubMed ID: 19889791
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic psychosocial stress exacerbates impairment of cognition and long-term potentiation in beta-amyloid rat model of Alzheimer's disease.
    Srivareerat M; Tran TT; Alzoubi KH; Alkadhi KA
    Biol Psychiatry; 2009 Jun; 65(11):918-26. PubMed ID: 18849021
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amygdala kindling-induced seizures selectively impair spatial memory. 1. Behavioral characteristics and effects on hippocampal neuronal protein kinase C isoforms.
    Beldhuis HJ; Everts HG; Van der Zee EA; Luiten PG; Bohus B
    Hippocampus; 1992 Oct; 2(4):397-409. PubMed ID: 1308196
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Butylphthalide improves learning and memory abilities of rats with Alzheimer's disease possibly by inhibiting P38 mitogen-activated protein kinase and enhancing extra-cellular signal regulated kinase expressions].
    Hou DR; Tian Y; Zhou J; Chen K; Wan S
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1592-5. PubMed ID: 19726301
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Powerful beneficial effects of benfotiamine on cognitive impairment and beta-amyloid deposition in amyloid precursor protein/presenilin-1 transgenic mice.
    Pan X; Gong N; Zhao J; Yu Z; Gu F; Chen J; Sun X; Zhao L; Yu M; Xu Z; Dong W; Qin Y; Fei G; Zhong C; Xu TL
    Brain; 2010 May; 133(Pt 5):1342-51. PubMed ID: 20385653
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acetyl-L-carnitine attenuates okadaic acid induced tau hyperphosphorylation and spatial memory impairment in rats.
    Yin YY; Liu H; Cong XB; Liu Z; Wang Q; Wang JZ; Zhu LQ
    J Alzheimers Dis; 2010; 19(2):735-46. PubMed ID: 20110616
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing alpha-secretase activity.
    Yang HQ; Pan J; Ba MW; Sun ZK; Ma GZ; Lu GQ; Xiao Q; Chen SD
    Eur J Neurosci; 2007 Jul; 26(2):381-91. PubMed ID: 17650113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 31. beta-Amyloid peptides impair PKC-dependent functions of metabotropic glutamate receptors in prefrontal cortical neurons.
    Tyszkiewicz JP; Yan Z
    J Neurophysiol; 2005 Jun; 93(6):3102-11. PubMed ID: 15659527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protein kinase C signal transduction regulation in physiological and pathological aging.
    Battaini F; Pascale A
    Ann N Y Acad Sci; 2005 Dec; 1057():177-92. PubMed ID: 16399894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Signaling pathways relevant to cognition-enhancing drug targets.
    Ménard C; Gaudreau P; Quirion R
    Handb Exp Pharmacol; 2015; 228():59-98. PubMed ID: 25977080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Postischemic PKC activation rescues retrograde and anterograde long-term memory.
    Sun MK; Hongpaisan J; Alkon DL
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14676-80. PubMed ID: 19667190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protein Kinase C Activation as a Potential Therapeutic Strategy in Alzheimer's Disease: Is there a Role for Embryonic Lethal Abnormal Vision-like Proteins?
    Talman V; Pascale A; Jäntti M; Amadio M; Tuominen RK
    Basic Clin Pharmacol Toxicol; 2016 Aug; 119(2):149-60. PubMed ID: 27001133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive enhancers (nootropics). Part 2: drugs interacting with enzymes.
    Froestl W; Muhs A; Pfeifer A
    J Alzheimers Dis; 2013; 33(3):547-658. PubMed ID: 23042218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.
    Schaeffer EL; Forlenza OV; Gattaz WF
    Psychopharmacology (Berl); 2009 Jan; 202(1-3):37-51. PubMed ID: 18853146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The aging brain, a key target for the future: the protein kinase C involvement.
    Pascale A; Amadio M; Govoni S; Battaini F
    Pharmacol Res; 2007 Jun; 55(6):560-9. PubMed ID: 17553691
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poststroke neuronal rescue and synaptogenesis mediated in vivo by protein kinase C in adult brains.
    Sun MK; Hongpaisan J; Nelson TJ; Alkon DL
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13620-5. PubMed ID: 18768786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cerebral microvessels in Alzheimer's have reduced protein kinase C activity.
    Grammas P; Moore P; Botchlet T; Hanson-Painton O; Cooper DR; Ball MJ; Roher A
    Neurobiol Aging; 1995; 16(4):563-9. PubMed ID: 8544906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.